Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
药物研究
/
经典阳性药
代谢酶
/
HMGCR
心血管系统
/ Atorvastatin hemicalcium salt

阿托伐他汀钙 /Atorvastatin hemicalcium salt {[allProObj[0].p_purity_real_show]}

货号：A499522 同义名： CI-981;Atorvastatin hemicalcium

Atorvastatin hemicalcium salt（CI-981）是一种口服活性的3-羟基-3-甲基戊二酰辅酶A（HMG-CoA）还原酶抑制剂，有效降低血脂。它抑制人SV-SMC增殖和侵袭的IC50值分别为0.39 μM和2.39 μM。

Atorvastatin hemicalcium salt 化学结构 CAS号：134523-03-8
Atorvastatin hemicalcium salt 化学结构
CAS号：134523-03-8
Atorvastatin hemicalcium salt 3D分子结构
CAS号：134523-03-8
Atorvastatin hemicalcium salt 化学结构 CAS号：134523-03-8
Atorvastatin hemicalcium salt 3D分子结构 CAS号：134523-03-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Atorvastatin hemicalcium salt 纯度/质量文件 产品仅供科研

货号：A499522 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
• Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
• ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
• ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
• Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >

Atorvastatin hemicalcium salt 生物活性

描述 Atorvastatin is an inhibitor of the enzyme 3-hydroxyl-3-methylglutaryl coenzyme A reductase used to prevent coronary heart disease,it has the ability to effectively decrease blood lipids[5].Atorvastatin hemicalcium salt inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively.[6]. Severe liver injury occurred in diabetic rats treated with 20mg/kg atorvastatin,it also increased the secretion of pro-inflammatory factors such as L-1, TNF, IL-6, and IL-18 by enhancing activation of the NF-B signal pathway in the livers of diabetic rats. Atorvastatin elevated the levels of ROS and reduced the antioxidant enzyme (SOD and CAT) activities. Atorvastatin also increased the expression of antiapoptotic protein BCL2 and decreased the expression of pro-apoptotic protein BAX in the livers of diabetic rats[7].Atorvastatin (20-30 mg/kg; oral gavage; once a day; for 28 days, Apolipoprotein E–deficient mice) treatment significantly reduces endoplasmic reticulum (ER) stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in mice. Proinflammatory cytokines such as IL-6, IL-8, IL-1β are all remarkably inhibited after Atorvastatin treatment[8].
作用机制 By down-regulating GRP78, caspase-12 and CHOP expressions in myocardial cells in rat heart failure after myocardial infarction, atorvastatin treatment decreased the apoptosis of myocardial cells, by which atorvastatin functions in protecting against heart failure[4].

Atorvastatin hemicalcium salt 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
human Caco2 cells Cytotoxic assay 72 h Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay, IC50=18.7 μM 22533316
human HCEC cells Cytotoxic assay 72 h Cytotoxicity against human HCEC cells assessed as reduction in cell survival after 72 hrs by MTT assay, IC50=20.3 μM 22533316
human HeLa cells Cytotoxic assay 72 h Cytotoxicity against human HeLa cells after 72 hrs by MTT assay, IC50=4.22 μM 22533316
human KB cells Cytotoxic assay 72 h Cytotoxicity against human KB cells after 72 hrs by MTT assay, IC50=1.97 μM 22533316

Atorvastatin hemicalcium salt 动物研究

Dose Rats: 10 mg/kg, max = 20 mg/kg[3]
Administration p.o.
Toxicity (LD50) Rats: 40 mg/kg p.o.[3]

Atorvastatin hemicalcium salt 参考文献

[1]Colhoun HM, Betteridge DJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-96.

[2]Zhang L, He H, Balschi JA. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am J Physiol Heart Circ Physiol. 2007;293(1):H457-66.

[3]Crespo MJ, Quidgley J. Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats. World J Diabetes. 2015;6(10):1168-78.

[4] Song XJ, et al. Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int J Med Sci. 2011;8(7):564-72.

[5] Santodomingo-Garzón T, et al. Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol. 2006 Sep;149(1):14-22.

[6] Turner NA, et al. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol. 2007 Oct;50(4):458-61.

[7] Tianshu Chu,et al. Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia via p38 MAPK Pathway Inhibition in a Rat Model of Vein Graft, Arq Bras Cardiol. 2020 Oct;115(4):630-636.

[8]Li Y, et al. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. PLoS One. 2017 Apr 3;12(4):e0174821.

Atorvastatin hemicalcium salt 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.87mL

0.17mL

0.09mL

4.33mL

0.87mL

0.43mL

8.66mL

1.73mL

0.87mL

Atorvastatin hemicalcium salt 技术信息

CAS号134523-03-8
分子式C66H68CaF2N4O10
分子量 1155.342
别名 CI-981;Atorvastatin hemicalcium;Atorvastatin Calcium
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place,Inert atmosphere,2-8°C
溶解方案

DMSO: 50 mg/mL(43.28 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用； 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方

IP 2% DMSO+2% Tween80+40% PEG300+water 8 mg/mL clear

PO 0.5% CMC-Na 60 mg/mL suspension

Tags: Atorvastatin hemicalcium salt | CI-981;Atorvastatin hemicalcium;Atorvastatin Calcium | Cardiovascular System | HMGCR | AmBeed-信号通路专用抑制剂 | Atorvastatin hemicalcium salt 纯度/质量文件 | Atorvastatin hemicalcium salt 生物活性 | Atorvastatin hemicalcium salt 细胞研究 | Atorvastatin hemicalcium salt 动物研究 | Atorvastatin hemicalcium salt 参考文献 | Atorvastatin hemicalcium salt 实验方案 | Atorvastatin hemicalcium salt 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z